Gemcitabine triphosphate nanoparticle (pHion Therapeutics)

N/A

Report date: 2023/10/09 16:53:41

Base Information

Drug NameGemcitabine triphosphate nanoparticle (pHion Therapeutics)
Drug Alias NameRALA-gemcitabine-triphosphate(dFdCTP) nanoparticlePTX-C1PTX_C1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom of Great Britain and Ireland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniespHion Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniespHion Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A